Society

Britain's Puberty Blocker Experiment

Britain's controversial puberty blocker trial is set to go ahead, with 226 children to be administered the drugs. The British High Court washed its hands of the matter - but was it right?

Britain's culture war over transgender policy.

Britain's bitter culture war over transgender policy is being closely watched by the rest of the world. Photo: Jory Mundy/Getty Images

Britain’s transgender wars took another turn last Friday, with the country’s High Court ruling that medics carrying out the so-called puberty blocker trial will be permitted to recruit children to take part and give them drugs to stop their natural biological development.

The drugs, which transgender activists say are necessary to prevent “trans children” from being permanently locked in an adult body that is of the opposite sex to the one they prefer, inhibit the body’s normal hormonal process and prevent the natural puberty phase in those to whom they are administered. Critics, by contrast, warn that the drugs – by suspending the body’s normal development – can leave those who take them permanently damaged, including by becoming infertile, emotionally stunted and with poor bone development.

The dispute has been at the center of Britain’s long-running trans wars for some time, and came about after the Cass Review recommended that puberty blockers no longer be administered routinely, which had been the position before the report was published.

An Ethical Quagmire

At the center of the row is, essentially, an ethical quagmire. On the one hand, supporters of puberty blockers say that by not being prescribed the drugs, children with severe gender dysphoria are denied any hope of the treatment they desperately desire, and are condemned to watch their body become fully sexually adult in the “incorrect” sex – something advocates say is emotionally and psychologically devastating, especially when the patients know that drugs which can prevent the process are available but denied to them.

Welcome to the comments section of the Štandard daily. Please take note of our guidelines, comments are moderated by us. You can contact the moderators at support@statement.com.

Participate in the discussion

Comments are available to subscribers only. If you'd like to join the discussion, choose a subscription starting at €6.72 per month.

All comments 0

    Register

    Comments are available to registered users only. If you'd like to join the discussion, register here.